Questcor Pharmaceuticals, Inc. (Headquarters) Announces Financial Results for 2006 and Outlook for 2007
UNION CITY, Calif.--(BUSINESS WIRE)--Questcor Pharmaceuticals, Inc. (AMEX:QSC) today reported its financial results for the quarter and year ended December 31, 2006. Total net product sales for the fourth quarter of 2006 were $3.4 million, up 87% from the fourth quarter of 2005. 2006 net sales of H.P. Acthar® Gel (repository corticotropin injection) (“Acthar”) increased 43% from 2005 to $12.1 million.